Pietro Quaglino
Department of Medical Sciences(BY)University of Turin(IT)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, Cutaneous Melanoma Detection and Management, Lymphoma Diagnosis and Treatment, Melanoma and MAPK Pathways, CAR-T cell therapy research
Most-Cited Works
- → Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial(2017)569 cited
- → Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression(2015)450 cited
- → European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017(2017)448 cited
- → Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model(2015)414 cited
- → Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases(2018)377 cited
- → Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial